Literature DB >> 7736464

Synthesis of the glycosyl amino acids N alpha-Fmoc-Ser[Ac4-beta-D-Galp-(1-->3)-Ac2-alpha-D-GalN3p]-OPfp and N alpha-Fmoc-Thr[Ac4-beta-D-Galp-(1-->3)-Ac2-alpha-D-GalN3p]-OPfp and the application in the solid-phase peptide synthesis of multiply glycosylated mucin peptides with Tn and T antigenic structures.

H Paulsen1, S Peters, T Bielfeldt, M Meldal, K Bock.   

Abstract

Two new glycosyl amino acids N alpha-Fmoc-Ser[Ac4-beta-D-Galp-(1-->3)-Ac2-alpha-D-GalN3p]-+ ++OPfp and N alpha-Fmoc-Thr[Ac4-beta-D-Galp-(1-->3)-Ac2-alpha-D-GalN3p]-+ ++OPfp were synthesized. Glycosylation of N alpha-Fmoc-Ser-OPfp or N alpha-Fmoc-Thr-OPfp with protected beta-D-Gal-(1-->3)-D-GalN3 donors afforded the glycosyl amino acids containing an activated C-terminus which could be utilized directly for solid-phase glycopeptide synthesis. The transformation of the 2-azido group into the acetamido derivative was achieved quantitatively at the end of the synthesis by treatment of the polymer-bound glycopeptide with thioacetic acid. The versatility of this strategy was demonstrated by the assembly of eight triply glycosylated mucin peptides which were synthesized simultaneously by multiple column techniques. The glycopeptides were prepared in order to investigate the substrate specificity of a galactosyltransferase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7736464     DOI: 10.1016/0008-6215(94)00292-n

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  12 in total

1.  A high-throughput O-glycopeptide discovery platform for seromic profiling.

Authors:  Ola Blixt; Emiliano Cló; Aaron S Nudelman; Kasper Kildegaard Sørensen; Thomas Clausen; Hans H Wandall; Philip O Livingston; Henrik Clausen; Knud J Jensen
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

2.  Specificity studies of an antibody developed against a mucin-type glycoprotein.

Authors:  S Haavik; M Nilsen; T Thingstad; H Barsett; D V Renouf; E F Hounsell; J F Codington
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

3.  Glycosylation of α-amino acids by sugar acetate donors with InBr3. Minimally competent Lewis acids.

Authors:  Mark R Lefever; Lajos Z Szabò; Bobbi Anglin; Michael Ferracane; Joanna Hogan; Lauren Cooney; Robin Polt
Journal:  Carbohydr Res       Date:  2012-01-28       Impact factor: 2.104

4.  Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates.

Authors:  I Brockhausen; D Toki; J Brockhausen; S Peters; T Bielfeldt; A Kleen; H Paulsen; M Meldal; F Hagen; L A Tabak
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

5.  Structural features of the human salivary mucin, MUC7.

Authors:  T L Gururaja; N Ramasubbu; P Venugopalan; M S Reddy; K Ramalingam; M J Levine
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

Review 6.  O-linked protein glycosylation structure and function.

Authors:  E F Hounsell; M J Davies; D V Renouf
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

Review 7.  Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.

Authors:  Danica P Galonić; David Y Gin
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

Review 8.  From imino sugars to cancer glycoproteins.

Authors:  H Paulsen; I Brockhausen
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

Review 9.  Glycopeptide drugs: A pharmacological dimension between "Small Molecules" and "Biologics".

Authors:  Christopher R Apostol; Meredith Hay; Robin Polt
Journal:  Peptides       Date:  2020-07-13       Impact factor: 3.750

10.  An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells.

Authors:  C Heuser; M Ganser; A Hombach; H Brand; G Denton; F-G Hanisch; H Abken
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.